| Literature DB >> 29940973 |
Xin Yang1, Xiaodong Li2, Yanjie Wang3, Xiaojing He2, Yang Zhao3.
Abstract
BACKGROUND: There is no evidence of the practices of obstetricians and gynecologists (OB/GYNs) regarding contraceptive use and determinants influencing contraceptive choices, including emergency methods such as combined oral contraceptives (COCs) and levonorgestrel intrauterine system (LNGIUS). This survey determines the practices and knowledge among Chinese female OB/GYNs regarding modern contraceptive methods.Entities:
Keywords: Combined oral contraceptives; Contraception; Female obstetricians/gynecologists; Knowledge and personal choice
Mesh:
Substances:
Year: 2018 PMID: 29940973 PMCID: PMC6019505 DOI: 10.1186/s12978-018-0557-9
Source DB: PubMed Journal: Reprod Health ISSN: 1742-4755 Impact factor: 3.223
Demographic characteristics of the respondents
| Characteristics | Number of respondents, |
|---|---|
| Age in years | |
| 22–29 | 126 (12.3) |
| 30–39 | 359 (35.0) |
| 40–49 | 355 (34.6) |
| 50–59 | 137 (13.3) |
| ≥ 60 | 50 (4.9) |
| Marital status | |
| Married/cohabiting | 1015 (98.8) |
| Single | 12 (1.2) |
| Parity | |
| Parous | 859 (83.6) |
| Nulliparous | 168 (16.4) |
| Grade of hospital | |
| 1 | 60 (5.8) |
| 2 | 431 (42.0) |
| 3 | 536 (52.2) |
| Specialty | |
| Gynecological endocrinology | 77 (7.5) |
| Gynecology | 465 (45.3) |
| Obstetrics | 79 (7.7) |
| Obstetrics and gynecology | 406 (39.5) |
| History of clinical confirmed diseases | |
| Hyperlipidemia | 66 (6.4) |
| Cardiovascular diseases | 36 (3.5) |
| Diabetes mellitus | 16 (1.6) |
| Low bone density/osteoporosis | 29 (2.8) |
| Hyperthyroidism/hypothyroidism | 5 (0.6) |
| Menstrual status | |
| Amenorrhea (menopause and total hysterectomy) | 197 (19.1) |
| Oligomenorrhea | 72 (7) |
| Moderate menstrual flow | 648 (63.1) |
| Menorrhagia | 110 (10.6) |
| Reasons for induced abortions | |
| Unreliable contraceptive method | 317 (55.5) |
| Failure of reliable contraceptive method | 108 (18.9) |
| Unintended pregnancy in spite of reliable contraceptive method | 64 (11.2) |
| Use of emergency contraception | 24 (4.2) |
| Disease | 5 (0.9) |
| Medications used during pregnancy | 7 (1.2) |
| Suspending embryo growth | 3 (0.5) |
| Abnormal development of fetus | 3 (0.5) |
Use of contraceptive methods among OB/GYNs or by their partners
| Method | Nulliparous, | Parous, | |
|---|---|---|---|
| Mean age, years | 27.7 | 40.0 | < 0.0001 |
| IUD | 2 (1.7) | 220 (42.6) | < 0.0001 |
| LNG-IUS | 1 (0.8) | 5 (1.0) | 1.000 |
| Condoms | 23 (19.2) | 54 (10.5) | 0.008 |
| Condom + rhythm | 25 (20.8) | 125 (24.2) | 0.431 |
| Condom + contraception for external use (spermicide) | 7 (5.8) | 27 (5.3) | 0.792 |
| COC | 3 (2.5) | 23 (4.4) | 0. 392 |
| Long-acting oral contraceptives | 0 (0) | 3 (0.627) | – |
| Subdermal implant | 0 (0) | 2 (0.4) | – |
| Female sterilization | 0 (0) | 2 (0.4) | – |
| Vasectomy | 0 (0) | 1 (0.01) | – |
| Coitus interruptus | 1 (0.8) | 37 (7.1) | 0.005 |
| Rhythm | 58 (48.3) | 17 (3.3) | < 0.0001 |
OB/GYNs’ knowledge and perceptions of contraceptives clinical application and side effects
| Questions | Yes, | No, | Don’t Know, |
|---|---|---|---|
| • Gestational trophoblastic patients may take low dose of COC | 210 (20.4) | 500 (48.7) | 317 (30.9) |
| • Should consider pregnancy 3–6 months after stopping the intake of COC | 252 (24.5) | 681 (66.3) | 94 (9.2) |
| • Taking COC for long term is harmful to health; however, interrupted intake is recommended | 193 (18.8) | 706 (68.7) | 128 (12.5) |
| • Taking COC may reduce the fertility of women | 77 (7.5) | 822 (80.0) | 128 (12.5) |
| • Taking COC for a long term may cause amenorrhea and premature ovarian failure | 109 (10.6) | 779 (75.9) | 139 (13.5) |
| • Taking COC may increase the risk of thrombi formation | 675 (65.7) | 215 (20.9) | 137 (13.3) |
| • Taking COC may increase the risk of breast cancer | 381 (37.1) | 466 (45.4) | 180 (17.5) |
| • Taking COC may cause weight gain | 511 (49.8) | 376 (36.6) | 140 (13.6) |